SPECTRE Associate Director Dr. Corri Levine was recently featured in Bloomberg for her expertise on the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo. The article explores why this outbreak has been particularly challenging to contain and how researchers and clinicians are working to better understand the virus and identify effective treatment strategies.
Drawing on her experience studying Bundibugyo Ebola, Dr. Levine provides scientific perspective on how this strain may differ from other Ebola viruses and why those differences matter in the current response.
As Associate Director of SPECTRE, Dr. Levine helps lead our efforts to advance special pathogen preparedness through education, research, and collaboration. We are proud to see her expertise contributing to important conversations about emerging infectious diseases.